全文获取类型
收费全文 | 1020347篇 |
免费 | 74013篇 |
国内免费 | 10353篇 |
专业分类
耳鼻咽喉 | 13477篇 |
儿科学 | 30185篇 |
妇产科学 | 28361篇 |
基础医学 | 140748篇 |
口腔科学 | 26674篇 |
临床医学 | 90806篇 |
内科学 | 202891篇 |
皮肤病学 | 20356篇 |
神经病学 | 77982篇 |
特种医学 | 40613篇 |
外国民族医学 | 406篇 |
外科学 | 154682篇 |
综合类 | 37709篇 |
现状与发展 | 24篇 |
一般理论 | 252篇 |
预防医学 | 72147篇 |
眼科学 | 23661篇 |
药学 | 76175篇 |
115篇 | |
中国医学 | 7778篇 |
肿瘤学 | 59671篇 |
出版年
2021年 | 11632篇 |
2019年 | 10380篇 |
2018年 | 13079篇 |
2017年 | 10779篇 |
2016年 | 11036篇 |
2015年 | 13830篇 |
2014年 | 18767篇 |
2013年 | 25138篇 |
2012年 | 34349篇 |
2011年 | 36813篇 |
2010年 | 22398篇 |
2009年 | 20417篇 |
2008年 | 32468篇 |
2007年 | 34056篇 |
2006年 | 34281篇 |
2005年 | 33768篇 |
2004年 | 30625篇 |
2003年 | 29547篇 |
2002年 | 28503篇 |
2001年 | 44216篇 |
2000年 | 45540篇 |
1999年 | 39490篇 |
1998年 | 12145篇 |
1997年 | 11274篇 |
1996年 | 10623篇 |
1995年 | 9869篇 |
1994年 | 9318篇 |
1993年 | 8381篇 |
1992年 | 29307篇 |
1991年 | 27949篇 |
1990年 | 27248篇 |
1989年 | 26084篇 |
1988年 | 24197篇 |
1987年 | 23734篇 |
1986年 | 22692篇 |
1985年 | 21557篇 |
1984年 | 16013篇 |
1983年 | 13632篇 |
1982年 | 8186篇 |
1979年 | 14696篇 |
1978年 | 10256篇 |
1977年 | 8662篇 |
1976年 | 8187篇 |
1975年 | 9001篇 |
1974年 | 10751篇 |
1973年 | 10217篇 |
1972年 | 9678篇 |
1971年 | 8939篇 |
1970年 | 8594篇 |
1969年 | 8040篇 |
排序方式: 共有10000条查询结果,搜索用时 318 毫秒
51.
52.
53.
54.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
55.
Dan-Feng Xu Bing Wu Jin-Xin Wang Jian Yu Jian-Xin Xie 《World Journal of Clinical Cases》2021,9(5):1096-1102
BACKGROUNDGuillain-Barré syndrome (GBS) is a rare disorder that typically presents with ascending weakness, pain, paraesthesias, and numbness, which mimic the findings in lumbar spinal stenosis. Here, we report a case of severe lumbar spinal stenosis combined with GBS.CASE SUMMARYA 70-year-old man with a history of lumbar spinal stenosis presented to our emergency department with severe lower back pain and lower extremity numbness. Magnetic resonance imaging confirmed the diagnosis of severe lumbar spinal stenosis. However, his symptoms did not improve postoperatively and he developed dysphagia and upper extremity numbness. An electromyogram was performed. Based on his symptoms, physical examination, and electromyogram, he was diagnosed with GBS. After 5 d of intravenous immunoglobulin (0.4 g/kg/d for 5 d) therapy, he gained 4/5 of strength in his upper and lower extremities and denied paraesthesias. He had regained 5/5 of strength in his extremities when he was discharged and had no symptoms during follow-up.CONCLUSIONGBS should be considered in the differential diagnosis of spinal disorder, even though magnetic resonance imaging shows severe lumbar spinal stenosis. This case highlights the importance of a careful diagnosis when a patient has a history of a disease and comes to the hospital with the same or similar symptoms. 相似文献
56.
57.
58.
59.
R. Di Raimondo J. Sanz-Esporrn R. Pl I. Sanz-Martn F. Luengo F. Vignoletti J. Nuez Mariano Sanz 《Clinical oral investigations》2020,24(7):2351-2361
To evaluate the changes in alveolar contour after guided bone regeneration (GBR) with two different combinations of biomaterials in dehiscence defects arou 相似文献
60.
首都医科大学通过60年辛勤耕耘、精益求精,秉承“顶天立地”的人才培养理念,为社会培养了大批高水平的学术型与应用型医药卫生人才。回顾学校60年来本专科教育、全科医学教育、国际教育、研究生教育的人才培养成果,以总结经验并鼓舞全体首医人进一步求真务实、凝心聚力、积极进取、追求卓越,努力将学校建设成为国际一流的研究型医科大学。 相似文献